EWGSOP2 Versus EWGSOP1: Impact on the Prevalence of Sarcopenia and Its Major Health Consequences

被引:55
|
作者
Locquet, Medea [1 ]
Beaudart, Charlotte [1 ]
Petermans, Jean [2 ]
Reginster, Jean-Yves [1 ]
Bruyere, Olivier [1 ]
机构
[1] Univ Liege, WHO, Collaborating Ctr Publ Hlth Aspects Musculoskelet, Dept Publ Hlth Epidemiol & Hlth Econ, Liege, Belgium
[2] CHU Liege, Geriatr Dept, Liege, Belgium
关键词
D O I
10.1016/j.jamda.2018.11.027
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
引用
收藏
页码:384 / 385
页数:2
相关论文
共 50 条
  • [1] Diagnosis and prevalence of sarcopenia in long-term care homes: EWGSOP2 versus EWGSOP1
    Isabel Rodriguez-Rejon, Ana
    Dolores Ruiz-Lopez, Maria
    Artacho, Reyes
    NUTRICION HOSPITALARIA, 2019, 36 (05) : 1074 - 1080
  • [2] Prevalence of sarcopenia according to EWGSOP1 and EWGSOP2 in older adults and their associations with unfavorable health outcomes: a systematic review
    Lara Vilar Fernandes
    Alexandre Elias Gomes Paiva
    Ana Clara Borges Silva
    Isabela Coelho de Castro
    Andrezza Fernanda Santiago
    Erick P. de Oliveira
    Laura Cristina Jardim Porto
    Aging Clinical and Experimental Research, 2022, 34 : 505 - 514
  • [3] Prevalence of sarcopenia according to EWGSOP1 and EWGSOP2 in older adults and their associations with unfavorable health outcomes: a systematic review
    Fernandes, Lara Vilar
    Paiva, Alexandre Elias Gomes
    Silva, Ana Clara Borges
    de Castro, Isabela Coelho
    Santiago, Andrezza Fernanda
    de Oliveira, Erick P.
    Porto, Laura Cristina Jardim
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (03) : 505 - 514
  • [4] Associations of EWGSOP1 and EWGSOP2 probable sarcopenia definitions with mortality: A comparative study
    Altinkaynak, Mustafa
    Gurel, Erdem
    Oren, Meryem Merve
    Kilic, Cihan
    Karan, Mehmet Akif
    Bahat, Gulistan
    CLINICAL NUTRITION, 2023, 42 (11) : 2151 - 2158
  • [5] Prevalence of sarcopenia in community-dwelling older adults in Ireland: comparison of EWGSOP1 and EWGSOP2 definitions
    Murphy, Caoileann
    McMorrow, Aoibheann
    Flanagan, Ellen
    Cummins, Helen
    McCarthy, Sinead
    McGowan, Maureen
    Rafferty, Sheena
    Egan, Brendan
    De Vito, Giuseppe
    Corish, Clare
    Roche, Helen
    PROCEEDINGS OF THE NUTRITION SOCIETY, 2020, 79 (OCE2) : E161 - E161
  • [6] Sarcopenia: Performance of the SARC-F Questionnaire According to the European Consensus Criteria, EWGSOP1 and EWGSOP2
    Hajaoui, Manon
    Locquet, Medea
    Beaudart, Charlotte
    Reginster, Jean-Yves
    Petermans, Jean
    Bruyere, Olivier
    JOURNAL OF THE AMERICAN MEDICAL DIRECTORS ASSOCIATION, 2019, 20 (09) : 1182 - 1183
  • [7] EWGSOP 2 VS. EWGSOP 1: IMPACT ON THE PREVALENCE OF SARCOPENIA AND ITS OUTCOMES
    Locquet, M.
    Beaudart, C.
    Petermans, J.
    Bruyere, O.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S275 - S276
  • [8] Recent consensus on definition and diagnosis for sarcopenia (EWGSOP2): agreement with the first consensus (EWGSOP1) and with tools for screening sarcopenia in older women
    Fernandes L.V.
    de Oliveira E.P.
    Castro I.C.
    de Melo C.M.
    Limirio L.S.
    Veiga E.P.
    Porto L.C.J.
    Santiago A.F.
    Nutrire, 46 (2)
  • [9] SARCOPENIA: PERFORMANCE OF THE SARC-F QUESTIONNAIRE ACCORDING TO THE EUROPEAN CONSENSUS CRITERIA, EWGSOP1 VS. EWGSOP2
    Hajaoui, M.
    Locquet, M.
    Beaudart, C.
    Reginster, J. -Y.
    Petermans, J.
    Bruyere, O.
    OSTEOPOROSIS INTERNATIONAL, 2019, 30 : S539 - S540
  • [10] EWGSOP1, EWGSOP2 OR SLOWNESS: WHICH IS THE BEST PREDICTOR OF MORTALITY RISK IN OLDER ADULTS?
    Spexoto, M. C. B.
    Ramirez, P. C.
    Maximo, R. O.
    Steptoe, A.
    Oliveira, C.
    Alexandre, T. S.
    AGING CLINICAL AND EXPERIMENTAL RESEARCH, 2022, 34 (SUPPL 1) : S224 - S225